Markets:

Overview

News

Currencies

International

Treasuries

BridgeBio Pharma, Inc. - Common Stock (NQ:BBIO)

73.49 -0.50 (-0.68%)

Streaming Delayed Price Updated: 1:33 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BridgeBio Pharma, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stocks Rise As Investors Bet On Bank Recovery ↗

March 29, 2023

Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.

Via Talk Markets

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories ↗

March 27, 2023

Benzinga

Via Benzinga

Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest ↗

March 27, 2023

BridgeBio Pharma Inc (NASDAQ: BBIO) is reportedly attracting takeover interest as some large pharmaceutical companies are studying a potential acquisition of the biotech firm.

Via Benzinga

First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 27, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

4 Analysts Have This to Say About BridgeBio Pharma ↗

March 07, 2023

Via Benzinga

Why Is BridgeBio Pharma (BBIO) Stock Up 60% Today? ↗

March 06, 2023

BBIO stock looks unstoppable today as BridgeBio Pharma diligently advances a treatment for a rare and unfortunate condition.

Via InvestorPlace

BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab)

March 23, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)

March 21, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma to Present Preliminary Findings on its Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)

March 17, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope

March 14, 2023

BridgeBio’s recent volatility is a perfect example of how good news often turns into bad news for biopharmaceutical companies.

Via MarketBeat

Topics Economy

Why BridgeBio Pharma Shares Are Falling Sharply ↗

March 08, 2023

BridgeBio Pharma Inc (NASDAQ: BBIO) shares are trading lower by 15.8% to $15.62 Wednesday morning after the company priced an offering of 8.82 million shares at $17 per share.

Via Benzinga

After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use ↗

March 08, 2023

Via Benzinga

BridgeBio Pharma Announces Pricing of Public Offering of Common Stock

March 08, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗

March 07, 2023

Via Benzinga

Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗

March 07, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

March 06, 2023

Via Benzinga

BridgeBio Pharma Announces Proposed Public Offering of Common Stock

March 06, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

Why BioMarin Shares Are Plunging Today? ↗

March 06, 2023

Biomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug, heating the competition.

Via Benzinga

These 2 Biotech Stocks Made Big Monday Moves ↗

March 06, 2023

Find out which was the winner and which was the loser.

Via The Motley Fool

Nasdaq Rises 50 Points; Ciena Earnings Top Expectations ↗

March 06, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday. The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P...

Via Benzinga

Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 06, 2023

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 06, 2023

Via Benzinga

Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher ↗

March 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500...

Via Benzinga

Why BridgeBio Pharma Stock Is Skyrocketing Today ↗

March 06, 2023

BridgeBio's latest results could set the bar in efficacy for treating the most common cause of short stature.

Via The Motley Fool

Stocks Rise As Bond Yields Fall; Investors Await Economic Data ↗

March 06, 2023

Wall Street is starting the week higher, as investors look ahead to upcoming economic data and new commentary from the Federal Reserve.

Via Talk Markets

BridgeBio's Dwarfism Candidate Shows Favorable Height Increase, Safety Profile ↗

March 06, 2023

BridgeBio Pharma Inc (NASDAQ: BBIO) announced results from PROPEL2 Phase 2 trial of infigratinib in children with achondroplasia, a genetic condition affecting a protein in the body called the...

Via Benzinga

What's Going On With Kala Pharmaceuticals Shares Today ↗

March 06, 2023

Kala Pharmaceutical (NASDAQ: KALA) shares skyrocketed more than 20% Monday morning on higher-than-average volume. On an average market day, Kala shares trade about 2.5 million times throughout the...

Via Benzinga

Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday ↗

March 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

What's Going On With Avalon GloboCare Shares Today ↗

March 06, 2023

The overall market ticked slightly higher in pre-market trading Monday morning, but Avalon Globocare Corp (NASDAQ: ALBT) shares really took off. Avalon GloboCare is a biotech company headquartered in...

Via Benzinga

Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January ↗

March 06, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 33,471.14 while the NASDAQ rose...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.